Commentary on Singh et al. (2020) Postzygotic Somatic Mutations in the Human Brain Expand the Threshold-Liability Model of Schizophrenia

by Peter S. Spencer, Glen E. Kisby
Published 2021-08-01

Is Neurodegenerative Disease a Long-Latency Response to Early-Life Genotoxin Exposure?

by Glen E. Kisby, Peter S. Spencer
Published 2011-09-01

Protocol for High-Throughput Screening of Neural Cell or Brain Tissue Protein Using a Dot-Blot Technique with Near-Infrared Imaging

by Anna C. Chlebowski, Glen E. Kisby
Published 2020-09-01

Unraveling 50-year-old clues linking neurodegeneration and cancer to cycad toxins: are microRNAs a common mediator?

by Peter eSpencer, Rebecca C Fry, Glen E Kisby
Published 2012-09-01

Western Pacific ALS-PDC: a prototypical neurodegenerative disorder linked to DNA damage and aberrant proteogenesis?

by Peter eSpencer, Rebecca eFry, Valerie S Palmer, Glen E Kisby
Published 2012-12-01

The cycad genotoxin MAM modulates brain cellular pathways involved in neurodegenerative disease and cancer in a DNA damage-linked manner.

by Glen E Kisby, Rebecca C Fry, Michael R Lasarev, Theodor K Bammler, Richard P Beyer, Mona Churchwell, Daniel R Doerge, Lisiane B Meira, Valerie S Palmer, Ana-Luiza Ramos-Crawford, Xuefeng Ren, Robert C Sullivan, Terrance J Kavanagh, Leona D Samson, Helmut Zarbl, Peter S Spencer
Published 2011-01-01